UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
April 27, 2017
Date of report (date of earliest event reported)
 
 
Surgery Partners, Inc.

(Exact name of registrant as specified in its charter)
 
 
 
 
 
 
 
 
Delaware
 
001-37576
 
47-3620923
(State or other jurisdictions of
incorporation or organization)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification Nos.)

40 Burton Hills Boulevard, Suite 500
Nashville, Tennessee 37215
(Address of principal executive offices) (Zip Code)

(615) 234-5900
(Registrant’s telephone number, including area code)
 

 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. o
 
 





Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 27, 2017, Christopher Laitala notified Surgery Partners, Inc. (the “Company”) of his decision to resign from the Board of Directors (the “Board”) of the Company, effective May 3, 2017. Mr. Laitala served on the Board of Directors of Surgery Center Holdings, Inc. since leading H.I.G. Capital, LLC's investment in December 2009. Mr. Laitala served on the Board since April 2015 and as chairman of the Board since August 2015. Mr. Laitala also served as a member of the Audit Committee of the Board until September 2016 and as a member of the Compensation Committee of the Board. Mr. Laitala’s resignation is part of a planned transition off of the Board following his resignation from H.I.G. Capital, LLC, the majority stockholder of the Company, and is not due to a disagreement with the Board or management or on any matter relating to the Company’s operations, policies or procedures.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
Surgery Partners, Inc.
 
 
 
 
By:
 /s/ MICHAEL T. DOYLE
 
 
 
Michael T. Doyle
Chief Executive Officer
Date: May 2, 2017